Status:
UNKNOWN
Resection of the Primary Tumor vs no Resection in Asymptomatic Patients With Unresectable Synchronous Liver Metastases From siNEN
Lead Sponsor:
CHU de Reims
Conditions:
Small Intestinal Neuroendocrine Tumor
Eligibility:
All Genders
18+ years
Brief Summary
Small Intestinal neuroendocrine Tumors (SiNETs) incidence is rising. Most of siNETs primaries are localized in jejunum/ileum. At the diagnosis, 50-70% of them present either lymph node (LN) and/or liv...
Eligibility Criteria
Inclusion
- 18 years old
- Patient with Si-NET and liver metastases considered as non-resectable
- Primary-related "asymptomatic" patient at diagnosis
- Diagnosed during the past 6 months
- No symptoms in relation with the primary or with mesenteric lesions
- Symptoms related to carcinoid syndrome allowed
Exclusion
- None
Key Trial Info
Start Date :
July 3 2018
Trial Type :
OBSERVATIONAL
Allocation :
ESTIMATED
End Date :
January 3 2025
Estimated Enrollment :
50 Patients enrolled
Trial Details
Trial ID
NCT03442959
Start Date
July 3 2018
End Date
January 3 2025
Last Update
July 12 2018
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Damien JOLLY
Reims, France